A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours
| Image |  |
|---|---|
| Description | scientific article published on 30 September 2014 |
| Author/s |
author: Breelyn A Wilky |
| Publication date | September 30, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |